Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema-Reference-Cited by-同舟云学术

Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema

Published:2020-09-24 Issue:13 Volume:383 Page:1242-1247
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Cohn Danny M.¹,Viney Nicholas J.¹,Fijen Lauré M.¹,Schneider Eugene¹,Alexander Veronica J.¹,Xia Shuting¹,Kaeser Gwendolyn E.¹,Nanavati Charvi¹,Baker Brenda F.¹,Geary Richard S.¹,Levi Marcel¹,Meijers Joost C.M.¹,Stroes Erik S.G.¹

Affiliation:

1. From the Departments of Vascular Medicine (D.M.C., L.M.F., E.S.G.S.) and Experimental Vascular Medicine (J.C.M.M.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, and the Department of Molecular and Cellular Hemostasis, Sanquin Research (J.C.M.M.), Amsterdam; Ionis Pharmaceuticals, Carlsbad, CA (N.J.V., E.S., V.J.A., S.X., G.E.K., C.N., B.F.B., R.S.G.); and the Department of Medicine, University College London Hospitals NHS Foundation Trust, and the Cardiometabolic Programme,...

Funder

Ionis Pharmaceuticals

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1915035

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Donidalorsen for Hereditary Angioedema;New England Journal of Medicine;2024-07-04

2. Hereditary angioedema: current therapeutic management and future approaches;Current Opinion in Allergy & Clinical Immunology;2024-05-13

3. Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system;Journal of Translational Medicine;2024-04-26

4. Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies;Expert Opinion on Investigational Drugs;2024-02-26

5. CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema;New England Journal of Medicine;2024-02